Cargando…

Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020

BACKGROUND: Dual contraceptive is the use of a barrier like condom along with any modern contraceptive methods which has double significance for the prevention STI including HIV and unintended pregnancy. The prevalence and determinants of dual contraceptive utilization described by different studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayele, Alemu Degu, Kassa, Bekalu Getnet, Beyene, Fentahun Yenealem, Sewyew, Dagne Addisu, Mihretie, Gedefaye Nibret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247245/
https://www.ncbi.nlm.nih.gov/pubmed/34193304
http://dx.doi.org/10.1186/s40834-021-00161-w
_version_ 1783716481057423360
author Ayele, Alemu Degu
Kassa, Bekalu Getnet
Beyene, Fentahun Yenealem
Sewyew, Dagne Addisu
Mihretie, Gedefaye Nibret
author_facet Ayele, Alemu Degu
Kassa, Bekalu Getnet
Beyene, Fentahun Yenealem
Sewyew, Dagne Addisu
Mihretie, Gedefaye Nibret
author_sort Ayele, Alemu Degu
collection PubMed
description BACKGROUND: Dual contraceptive is the use of a barrier like condom along with any modern contraceptive methods which has double significance for the prevention STI including HIV and unintended pregnancy. The prevalence and determinants of dual contraceptive utilization described by different studies were highly inconsistent in Ethiopia. Therefore, this systematic review and meta-analysis aimed to estimate the pooled prevalence and determinants of dual contraceptive utilization among HIV positive women in Ethiopia. METHODS: International database mainly Pub Med, Google scholar, HINARI, EMBASE, Cochrane Library, AJOL was applied to identify original studies. STATA software version 14 was applied to analyze the pooled prevalence of dual contraceptive. I(2) test statistics was computed to check the presence of heterogeneity across the studies and eggers test was used to identify publication bias. The pooled prevalence of dual contraceptive utilization was estimated by using a random effects model. The associations between determinants and dual contraceptive utilization were evaluated by using both random and fixed effect models. RESULT: A total 9 studies with 9168 HIV positive women were enrolled in this study. The pooled prevalence of dual contraceptive utilization among HIV positive women in Ethiopia was 26.14% (95% CI 21.20–31.08). Disclosure of HIV status (OR = 4.18,95%CI:2.26–7.72), partner involvement in post-test counselling (OR = 2.31,95%CI:1.63–3.25), open discussion about dual contraceptive with partner (OR = 4.27 95% CI:1.69–10.77), provision of counselling on dual contraceptives by health care provider (OR = 4.47,95% CI:3.81–5.24) and CD4 count > 350 cells/ mm(3) (OR = 3.87,95%CI:3.53–4.23) were among the significant factors associated with dual contraceptive utilization. CONCLUSION: The overall prevalence of dual contraceptive utilization among HIV positive women was significantly low. Disclosure of HIV status, partner involvement in post-test counselling, open discussion about dual contraceptive with partner, counselling on dual contraceptive by health care provider and CD4 count > 350 cells/ mm(3) were positively affect dual contraceptive utilization. This study implies the need to develop plans and policies to improve partner involvement posttest counseling, integrate the counseling and provision of dual contraceptive at ART clinic at each level of health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40834-021-00161-w.
format Online
Article
Text
id pubmed-8247245
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82472452021-07-06 Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020 Ayele, Alemu Degu Kassa, Bekalu Getnet Beyene, Fentahun Yenealem Sewyew, Dagne Addisu Mihretie, Gedefaye Nibret Contracept Reprod Med Review BACKGROUND: Dual contraceptive is the use of a barrier like condom along with any modern contraceptive methods which has double significance for the prevention STI including HIV and unintended pregnancy. The prevalence and determinants of dual contraceptive utilization described by different studies were highly inconsistent in Ethiopia. Therefore, this systematic review and meta-analysis aimed to estimate the pooled prevalence and determinants of dual contraceptive utilization among HIV positive women in Ethiopia. METHODS: International database mainly Pub Med, Google scholar, HINARI, EMBASE, Cochrane Library, AJOL was applied to identify original studies. STATA software version 14 was applied to analyze the pooled prevalence of dual contraceptive. I(2) test statistics was computed to check the presence of heterogeneity across the studies and eggers test was used to identify publication bias. The pooled prevalence of dual contraceptive utilization was estimated by using a random effects model. The associations between determinants and dual contraceptive utilization were evaluated by using both random and fixed effect models. RESULT: A total 9 studies with 9168 HIV positive women were enrolled in this study. The pooled prevalence of dual contraceptive utilization among HIV positive women in Ethiopia was 26.14% (95% CI 21.20–31.08). Disclosure of HIV status (OR = 4.18,95%CI:2.26–7.72), partner involvement in post-test counselling (OR = 2.31,95%CI:1.63–3.25), open discussion about dual contraceptive with partner (OR = 4.27 95% CI:1.69–10.77), provision of counselling on dual contraceptives by health care provider (OR = 4.47,95% CI:3.81–5.24) and CD4 count > 350 cells/ mm(3) (OR = 3.87,95%CI:3.53–4.23) were among the significant factors associated with dual contraceptive utilization. CONCLUSION: The overall prevalence of dual contraceptive utilization among HIV positive women was significantly low. Disclosure of HIV status, partner involvement in post-test counselling, open discussion about dual contraceptive with partner, counselling on dual contraceptive by health care provider and CD4 count > 350 cells/ mm(3) were positively affect dual contraceptive utilization. This study implies the need to develop plans and policies to improve partner involvement posttest counseling, integrate the counseling and provision of dual contraceptive at ART clinic at each level of health system. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40834-021-00161-w. BioMed Central 2021-07-01 /pmc/articles/PMC8247245/ /pubmed/34193304 http://dx.doi.org/10.1186/s40834-021-00161-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Ayele, Alemu Degu
Kassa, Bekalu Getnet
Beyene, Fentahun Yenealem
Sewyew, Dagne Addisu
Mihretie, Gedefaye Nibret
Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title_full Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title_fullStr Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title_full_unstemmed Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title_short Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020
title_sort dual contraceptive utilization and determinant factors among hiv positive women in ethiopia: a systematic review and meta-analysis, 2020
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247245/
https://www.ncbi.nlm.nih.gov/pubmed/34193304
http://dx.doi.org/10.1186/s40834-021-00161-w
work_keys_str_mv AT ayelealemudegu dualcontraceptiveutilizationanddeterminantfactorsamonghivpositivewomeninethiopiaasystematicreviewandmetaanalysis2020
AT kassabekalugetnet dualcontraceptiveutilizationanddeterminantfactorsamonghivpositivewomeninethiopiaasystematicreviewandmetaanalysis2020
AT beyenefentahunyenealem dualcontraceptiveutilizationanddeterminantfactorsamonghivpositivewomeninethiopiaasystematicreviewandmetaanalysis2020
AT sewyewdagneaddisu dualcontraceptiveutilizationanddeterminantfactorsamonghivpositivewomeninethiopiaasystematicreviewandmetaanalysis2020
AT mihretiegedefayenibret dualcontraceptiveutilizationanddeterminantfactorsamonghivpositivewomeninethiopiaasystematicreviewandmetaanalysis2020